Page 16 - Sera Prognostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sera Prognostics (NASDAQ:SERA – Get Rating) and Celcuity (NASDAQ:CELC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Insider & Institutional Ownership 63.2% of Sera Prognostics shares are […]

Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Sera Prognostics to related companies based on the strength of its valuation, earnings, profitability, dividends, institutional ownership, risk and analyst recommendations. Insider and Institutional Ownership 63.2% of […]

Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 public companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Sera Prognostics to related companies based on the strength of its analyst recommendations, earnings, profitability, dividends, valuation, risk and institutional ownership. Valuation and Earnings This table compares […]

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its peers? We will compare Sera Prognostics to related businesses based on the strength of its analyst recommendations, institutional ownership, valuation, risk, profitability, dividends and earnings. Profitability This table compares […]